AIKIDO PHARMA INC (AIKI)       3.56  +0.01 (+0.28%)

3.56  +0.01 (+0.28%)

US0088753043 - Common Stock

AIKIDO PHARMA INC3.56

NASDAQ:AIKI (12/21/2022, 7:17:10 PM)+0.01 (+0.28%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) 03-27 2023-03-27
Ins Owners 4.37% Inst Owners N/A
Market Cap 19.53M Shares 5.49M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.86
IPO 03-18 1980-03-18

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AIKI Daily chart

Company Profile

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The Company’s pipeline consists of patented technology from universities and researchers. The firm advances its therapeutic drug pipeline through a collaboration with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The company is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Its pancreatic drug candidate, DHA-dFdC, developed at and licensed from the University of Texas at Austin, is a chemotherapy treatment for advanced pancreatic cancer.

Company Info

AIKIDO PHARMA INC

One Rockefeller Plaza, 11Th Floor

New York City NEW YORK 10020

P: 13473217646.0

CEO: Anthony Hayes

Employees: 4

Website: https://aikidopharma.com/

AIKI News

News Image2 months ago - AIkido Pharma Inc.AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

/PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced the successful initial public offering ("IPO") of ASP Isotopes...

News Image4 months ago - AIkido Pharma Inc.AIkido Share Repurchase Continues

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share...

News Image5 months ago - Market News VideoWednesday 9/14 Insider Buying Report: ISSC, AIKINews Image5 months ago - Dominari Financial, Inc.Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer

/PRNewswire/ -- Dominari Financial, Inc., the financial services subsidiary of AIkido Pharma Inc., (NASDAQ: AIKI) has entered into an exclusive agreement for...

News Image7 months ago - AIkido Pharma Inc.AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary

/PRNewswire/ -- Anthony Hayes, CEO of AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company"), announced the hiring of Carlos Aldavero as President of...

News Image8 months ago - AIkido Pharma Inc.AIkido Inc. Announces the Formation of a New Financial Services Subsidiary

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") announced the formation of a wholly owned subsidiary with the purpose of making...

AIKI Twits

Here you can normally see the latest stock twits on AIKI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example